M.D. Anderson Cancer Center: all 3,044 studies

Page 5 of 31. Open to participants first (578), then studies with results posted, then the rest; newest registration first within each.

• Parenting Support Intervention for Families Coping With Metastatic or Locally Recurrent Solid Tumor DiagnosisRecruitingNCT05059678Not applicable
• Neutrophil Extracellular Traps Formation in Breast Cancer Patients Taking TamoxifenRecruitingNCT05056857
• Comparison of Synthetic Mammography Versus Full-Field Digital Mammography in Image Interpretation and Performance MetricsRecruitingNCT05056818
• A Phase 1 With Extension Cohort, Single Arm, Single Center, Open Label Trial of Belantamab Mafodotin for the Treatment of High-Risk Smoldering Multiple MyelomaRecruitingNCT05055063Phase 1
• Formulating Expert Consensus Guidelines in Cancer Care Using the Delphi MethodRecruitingNCT05054413
• Patient-Specific Computational Walking Models in Improving Surgical and Rehabilitation Treatment in Patients With Pelvic SarcomasRecruitingNCT05054335Not applicable
• Modifying Metabolic Syndrome and Cardiovascular Risk for Prostate Cancer Patients on ADT Using a Risk Factor Modification Program and Continuous Fitbit MonitoringRecruitingNCT05054296Phase 2
• A Randomized Controlled Trial of Inhaled Tranexamic Acid for the Treatment of Pulmonary Hemorrhage in Cancer PatientsRecruitingNCT05053867Phase 3
• High Dose-Rate Brachytherapy for the Treatment of Both Primary and Secondary Unresectable Liver MalignanciesRecruitingNCT05053555Not applicable
• PROSPECT - Profiling of Resistance Patterns & Oncogenic Signaling Pathways in Evaluation of Cancers of the Thorax and Therapeutic Target IdentificationRecruitingNCT05049837
• Determine the Utility of Liquid Biopsies and Tumor Molecular Profiling in Predicting Recurrence in Endometrial CancersRecruitingNCT05049538
• A Phase II Study of Nivolumab With Ipilimumab and Cabozantinib in Patients With Untreated Renal Cell Carcinoma Brain MetastasesRecruitingNCT05048212Phase 2
• Clinicopathologic and Ancillary Testing of Primary Clear Cell Carcinoma of the CervixRecruitingNCT05046080
• Diagnostic Performance Of Non-Endorectal Coil Multiparametric Magnetic Resonance Imaging Of Prostate With Flexible AIR Coil (DoNEMAC Study)RecruitingNCT05043012Not applicable
• Comparative Performance of Molecular Breast Imaging (MBI) to Magnetic Resonance Imaging (MRI) of the Breast in Identifying and Excluding Breast Carcinoma in Women at High Risk for Breast CancerRecruitingNCT05042687Not applicable
• Hyperpolarized 129-Xenon Imaging in Adult Hematopoietic Cell Transplant Recipients With Pulmonary ImpairmentRecruitingNCT05041140
• IACS-6274 With or Without Bevacizumab and Paclitaxel for the Treatment of Advanced Solid TumorsRecruitingNCT05039801Phase 1
• Phase I/II Randomized Study of NBTXR3 Activated by Abscopal or RadScopal Radiation in Combination With Immunotherapy (Anti-PD-1/L-1) for Patients With Advanced Solid MalignanciesRecruitingNCT05039632Phase 1/2
• Magnetic Sentinel Lymph Node Mapping in Gastric CancerNot yet recruitingNCT05038098Phase 1
• A Phase 2 Single-Arm Open-Label Pilot Trial Evaluating Zanidatamab (ZW25) in Patients With Early Stage HER2/Neu Positive (HER2+) Breast Cancer (BC)RecruitingNCT05035836Phase 2
• Immunotherapy With Chemotherapy and Chemoradiation for Advanced Squamous Cancer of Nasal Cavity / Paranasal Sinuses (I-NAPA)RecruitingNCT05027633Phase 2
• Binimetinib and Encorafenib for the Treatment of Metastatic Melanoma and Central Nervous System MetastasesRecruitingNCT05026983Phase 2
• The Impact of COVID-19 on Pulmonary ProceduresRecruitingNCT05022446
• Atezolizumab and Cabozantinib for the Treatment of Adolescents and Young Adults With Recurrent or Metastatic Osteosarcoma, TACOS StudyRecruitingNCT05019703Phase 2
• Neurocognitive Outcomes After Whole Brain Radiation Therapy for Hematologic MalignanciesRecruitingNCT05011045
• Decitabine Alone or in Combination With Venetoclax, Gilteritinib, Enasidenib, or Ivosidenib as Maintenance Therapy for the Treatment of Acute Myeloid Leukemia in RemissionRecruitingNCT05010772Phase 1
• ASTX727, Venetoclax, and Gilteritinib for the Treatment of Newly Diagnosed, Relapsed or Refractory FLT3-Mutated Acute Myeloid Leukemia or High-Risk Myelodysplastic SyndromeRecruitingNCT05010122Phase 1/2
• Cardiovascular Injury and Cardiac Fitness in Locally Advanced Non-Small Cell Lung Cancer Patients Receiving Model Based Personalized ChemoradiationRecruitingNCT05010109Not applicable
• Phase I CB-NK-TGF-ßR2-/NR3C1- in rGBMRecruitingNCT04991870Phase 1
• Patient Perceptions Around Quality of Care Through Telemedicine in Neuro-OncologyRecruitingNCT04988009
• Impact of Project ECHO on Improving the Quality of Palliative Care in Patients With Advanced Cancer and Their Caregivers in Underserved Areas of Kenya, Nigeria, Ghana, South Africa, India, and EthiopiaRecruitingNCT04984551Phase 2
• Short Stitch Versus Traditional Suture for the Prevention of Incisional Hernia After Open HepatectomyRecruitingNCT04982653Phase 2
• Androgen Ablation Therapy With or Without Niraparib After Radiation Therapy for the Treatment of High-Risk Localized or Locally Advanced Prostate CancerRecruitingNCT04947254Phase 2
• Predictive Biomarkers for Pneumonitis After Chemoradiotherapy and Immunotherapy in Patients With Non-small Cell Lung CancerRecruitingNCT04913311
• Local Consolidative Therapy and Durvalumab for Oligoprogressive and Polyprogressive Stage III NSCLC After Chemoradiation and Anti-PD-L1 TherapyRecruitingNCT04892953Phase 2
• Outcomes After Chimeric Antigen Receptor Therapy and Radiation Therapy for Hematologic MalignanciesRecruitingNCT04888338
• Larotrectinib for the Treatment of NTRK Amplification Positive, Locally Advanced or Metastatic Solid TumorsRecruitingNCT04879121Phase 2
• Adoption of Audio Recording in the Outpatient Supportive Care CenterNot yet recruitingNCT04871477
• Cardiovascular Events Among Adults Patients With Relapsed or Refractory Aggressive B-Cell Lymphoma Treated With Standard of Care Chimeric Antigen Receptor T Cell TherapyRecruitingNCT04870853
• Survey of Current Interventional and Diagnostic Imaging Residents After Participation in Endovascular Simulator TrainingRecruitingNCT04832698
• An Investigational Scan (Intravoxel Incoherent Motion Diffusion Weighted Imaging) for the Evaluation of Colorectal Cancer Liver Metastases Treatment ResponseRecruitingNCT04796818Not applicable
• Canakinumab for the Prevention of Lung Cancer, the Can-Prevent-Lung TrialRecruitingNCT04789681Phase 2
• Walking After Surgery to Improve Recovery and Outcomes After Surgery, AIRTECH StudyRecruitingNCT04783168Not applicable
• Quality of Life, Lifestyle, and Psychosocial Factors in Patients With MelanomaRecruitingNCT04778449
• Expressive Writing for the Management of Stress in Cancer SurvivorsRecruitingNCT04776941Not applicable
• Decitabine/Cedazuridine and Venetoclax in Combination With Ivosidenib or Enasidenib for the Treatment of Relapsed or Refractory Acute Myeloid LeukemiaRecruitingNCT04774393Phase 1/2
• Serial Advanced Magnetic Resonance Imaging Scan for Guidance of Personalized Adaptive Radiotherapy for High Grade GliomaRecruitingNCT04771806
• Avapritinib for the Treatment of CKIT or PDGFRA Mutation-Positive Locally Advanced or Metastatic Malignant Solid TumorsRecruitingNCT04771520Phase 2
• Medical Data Collection for the Evaluation of Radiofrequency Ablation and Cement Augmentation for the Treatment of Secondary Metastases to the SpineRecruitingNCT04751422
• Evaluating the Impact of Limited Compared With Intense Post-Operative Surveillance on Patient-Reported Outcomes in Patients With Stage II-III Soft Tissue Sarcoma of the Trunk and ExtremitiesRecruitingNCT04751409Phase 2
• Testing of an Educational Tool for Patients With Melanoma and Pre-Existing Autoimmune Disease Who Are Candidates for Immune Checkpoint InhibitorsRecruitingNCT04751396
• PACIFIC: Primary Mediastinal Large B-cell Lymphoma Treated With Antibody Therapy, Checkpoint Inhibitor in Frontline With ImmunoChemotherapyRecruitingNCT04745949Phase 2
• Addition of Cord Blood Tissue-Derived Mesenchymal Stromal Cells to Ruxolitinib for the Treatment of Steroid-Refractory Acute Graft Versus Host DiseaseRecruitingNCT04744116Early Phase 1
• Minimal Residual Disease Assessment in Patients With Colorectal Cancer, the MiRDA-C StudyRecruitingNCT04739072
• Establishing a Tumor Registry for Patients With Neuroendocrine Carcinoma of the CervixRecruitingNCT04723095
• Baloxavir and Oseltamivir for the Treatment of Severe Influenza Infection in Immunocompromised PatientsRecruitingNCT04712539Phase 2
• Venetoclax to Improve Outcomes of Fractionated Busulfan Regimen in Patients With High-Risk AML and MDSRecruitingNCT04708054Phase 2/3
• Talazoparib and Palbociclib, Axitinib, or Crizotinib for the Treatment of Advanced or Metastatic Solid Tumors, TalaCom TrialRecruitingNCT04693468Phase 1
• Cryoablation Combined With Stereotactic Body Radiation Therapy for the Treatment of Painful Bone Metastases, the CROME TrialRecruitingNCT04693377Not applicable
• Role of Diet on the Microbiome of the Digestive SystemRecruitingNCT04666727
• The Rise in Robotic Atypical SegmentectomiesRecruitingNCT04644952
• Evaluation of Portal Vein Stenting in Patients With Portal Vein Stenosis and Gastrointestinal CancersRecruitingNCT04629677
• Chemotherapy and Radiation Therapy for the Treatment of IDH Wildtype Gliomas or Non-histological (Molecular) GlioblastomasRecruitingNCT04623931Phase 2
• NBTXR3, Chemotherapy, and Radiation Therapy for the Treatment of Esophageal CancerRecruitingNCT04615013Phase 1
• Self-monitoring Focus Groups With Vibrant Lives Pasadena ParticipantsRecruitingNCT04611087
• Evaluating Clonogenic Epithelial Cell Populations in Patients With Bronchiolitis Obliterans SyndromeRecruitingNCT04604522
• Nicotine Replacement Therapy, Counseling, Varenicline, and Bupropion for Smoking Cessation, the PISCES I TrialRecruitingNCT04604509Phase 4
• Educating Smokers About Lung Cancer Screening Using Tobacco QuitlinesRecruitingNCT04595422Not applicable
• Nodal Radiation Therapy for Sentinel Lymph Node Positive MelanomaRecruitingNCT04594187Phase 2
• An Investigational Scan (hpMRI) for Monitoring Treatment Response in Patients With Thyroid Cancer and Other Malignancies of the Head and Neck Undergoing Radiation Therapy and/or Systemic TherapyRecruitingNCT04589624Phase 1
• Minimally Invasive Surgery After Neoadjuvant Chemotherapy for the Treatment of Stage IIIC-IV Ovarian, Primary Peritoneal, or Fallopian Tube Cancer, LANCE TrialRecruitingNCT04575935Phase 3
• The Effect of COVID-19 Pandemic on Adolescent and Young Adult Cancer Patients and SurvivorsRecruitingNCT04551378
• CPX-351 and Ivosidenib for the Treatment of IDH1 Mutated Acute Myeloid Leukemia or High-Risk Myelodysplastic SyndromeRecruitingNCT04493164Phase 2
• Assessment of the Psychosocial Impact of the COVID-19 Pandemic on the MD Anderson Cancer Center WorkforceRecruitingNCT04491292
• Customized Neuro-Imaging Referenced Symptom Video for the Reduction of Patient and Caregiver Anxiety Around Radiation Treatment for Brain TumorsRecruitingNCT04479696Not applicable
• Well-Being and Health-Related Quality of Life in Melanoma Patients During COVID-19 PandemicRecruitingNCT04474301
• Acalabrutinib, Lenalidomide, and Rituximab for the Treatment of CD20 Positive Stage III-IV, Grade 1-3a Follicular LymphomaRecruitingNCT04404088Phase 2
• Nivolumab, Fluorouracil, and Interferon Alpha 2B for the Treatment of Unresectable Fibrolamellar CancerRecruitingNCT04380545Phase 1/2
• MRE Scan for the Assessment of Differences in Tissue Stiffness Between Radiation Necrosis and Recurrent Glioma in Patients With Previously Treated GliomasRecruitingNCT04373720Not applicable
• Serial Magnetic Resonance Imaging for the Prediction of Radiation-Induced Changes in Normal Tissue of Patients With Oral Cavity or Skull Base TumorsRecruitingNCT04265430Phase 4
• A Phase II, Open-Label, Study of Subcutaneous Canakinumab, an Anti-IL-1β Human Monoclonal Antibody, for Patients With Low or Int-1 Risk IPSS/IPSS-R Myelodysplastic Syndromes and Chronic Myelomonocytic LeukemiaRecruitingNCT04239157Phase 2
• Natural History of Medullary Thyroid Cancer to Inform Advanced Disease ManagementRecruitingNCT04216732
• Venetoclax, SL-401, and Chemotherapy for the Treatment of Blastic Plasmacytoid Dendritic Cell NeoplasmRecruitingNCT04216524Phase 2
• Implantable Microdevice for the Delivery of Drugs and Their Effect on Tumors in Patients With Metastatic or Recurrent SarcomaRecruitingNCT04199026Not applicable
• Nasal Inhalation of Isopropyl Alcohol for the Treatment of Nausea in Patients With CancerNot yet recruitingNCT04181463Phase 2
• Nelfinavir, Cisplatin, and External Beam Radiation Therapy for the Treatment of Locally Advanced Vulvar Cancer That Cannot Be Removed by SurgeryRecruitingNCT04169763Phase 1
• Acalabrutinib and Venetoclax With or Without Early Obinutuzumab for the Treatment of High Risk, Recurrent, or Refractory Chronic Lymphocytic Leukemia or Small Lymphocytic LymphomaRecruitingNCT04169737Phase 2
• Impact of COVID-19 Pandemic on Out-of-Pocket Costs, Lost Wages, and Unemployment in Patients With Breast Cancer Undergoing Breast SurgeryRecruitingNCT04169542
• High Dose Steroid Therapy (Prednisone or Methylprednisolone) for the Improvement of Symptoms of Late Radiation-Associated Lower Cranial Neuropathy in Oropharyngeal Cancer SurvivorsRecruitingNCT04151082Phase 1/2
• Azacitidine, Venetoclax, and Gilteritinib in Treating Patients With Recurrent/Refractory FLT3-Mutated Acute Myeloid Leukemia, Chronic Myelomonocytic Leukemia, or High-Risk Myelodysplastic Syndrome/Myeloproliferative NeoplasmRecruitingNCT04140487Phase 1/2
• Olaparib With Cediranib or AZD6738 for the Treatment of Advanced or Metastatic Germline BRCA Mutated Breast CancerRecruitingNCT04090567Phase 2
• Cladribine, Idarubicin, Cytarabine, and Quizartinib in Treating Patients With Newly Diagnosed, Relapsed, or Refractory Acute Myeloid Leukemia or High-Risk Myelodysplastic SyndromeRecruitingNCT04047641Phase 1/2
• Fecal Microbiota Transplantation in Treating Immune-Checkpoint Inhibitor Induced-Diarrhea or Colitis in Genitourinary Cancer PatientsRecruitingNCT04038619Phase 1
• Bendamustine With or Without Cyclophosphamide in Preventing GVHD in Patients Undergoing Stem Cell TransplantRecruitingNCT04022239Phase 1/2
• Web-Based Program in Helping Patients With Head and Neck Cancer Adhere to Swallowing Exercises and Coping StrategiesRecruitingNCT04003051Phase 2
• Negative Pressure Wound Therapy in Healing Abdominal Incision in Obese Patients Undergoing Breast Reconstruction SurgeryRecruitingNCT04003038Not applicable
• Talazoparib and Radiation Therapy in Treating Patients With Locally Recurrent Gynecologic CancersRecruitingNCT03968406Phase 1
• Dyadic Yoga Intervention in Improving Physical Performance and Quality of Life in Patients With Stage I-IV Non-small Cell Lung or Esophageal Cancer Undergoing Radiotherapy and Their CaregiversRecruitingNCT03948100Not applicable
• Lymphovenous Bypass Procedure Before Underarm Lymph Node Surgery in Preventing Lymphedema in Patients With Inflammatory or Locally Advanced Non-inflammatory Breast Cancer or MelanomaRecruitingNCT03941756Not applicable
• HSV G207 in Children With Recurrent or Refractory Cerebellar Brain TumorsRecruitingNCT03911388Phase 1

← M.D. Anderson Cancer Center overview and focus areas